Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome

The Korean Society of Haematology AML/MDS Working Party

Research output: Contribution to journalLetter

Original languageEnglish
JournalBritish Journal of Haematology
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Myelodysplastic Syndromes
Proxy
Therapeutics
lenalidomide

Keywords

  • Hypomethylating agent
  • lenalidomide
  • MDS

ASJC Scopus subject areas

  • Hematology

Cite this

Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome. / The Korean Society of Haematology AML/MDS Working Party.

In: British Journal of Haematology, 01.01.2019.

Research output: Contribution to journalLetter

@article{7f4c9db45e7046c5937cda5031a8ca53,
title = "Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome",
keywords = "Hypomethylating agent, lenalidomide, MDS",
author = "{The Korean Society of Haematology AML/MDS Working Party} and Hawk Kim and Lee, {Je Hwan} and Lee, {Won Sik} and Inho Kim and Moon, {Joon Ho} and Choi, {Chul Won} and Lee, {Ho Sup} and Jinny Park and Yunsuk Choi and Shin, {Ho Jin} and Cho, {Su Hee} and Kim, {Kyoung Ha} and Kim, {Sung Yong} and Kim, {Yoo Jin}",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/bjh.15991",
language = "English",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome

AU - The Korean Society of Haematology AML/MDS Working Party

AU - Kim, Hawk

AU - Lee, Je Hwan

AU - Lee, Won Sik

AU - Kim, Inho

AU - Moon, Joon Ho

AU - Choi, Chul Won

AU - Lee, Ho Sup

AU - Park, Jinny

AU - Choi, Yunsuk

AU - Shin, Ho Jin

AU - Cho, Su Hee

AU - Kim, Kyoung Ha

AU - Kim, Sung Yong

AU - Kim, Yoo Jin

PY - 2019/1/1

Y1 - 2019/1/1

KW - Hypomethylating agent

KW - lenalidomide

KW - MDS

UR - http://www.scopus.com/inward/record.url?scp=85067381860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067381860&partnerID=8YFLogxK

U2 - 10.1111/bjh.15991

DO - 10.1111/bjh.15991

M3 - Letter

AN - SCOPUS:85067381860

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

ER -